233 related articles for article (PubMed ID: 12696579)
21. The 26-week Tg.rasH2 mice carcinogenicity studies: microscopic examination of only select tissues in low- and mid-dose groups.
Paranjpe MG; Denton MD; Elbekai RH
Toxicol Pathol; 2014 Oct; 42(7):1153-7. PubMed ID: 23960167
[TBL] [Abstract][Full Text] [Related]
22. Lack of modifying effects of eugenol on development of lung proliferative lesions induced by urethane in transgenic mice carrying the human prototype c-Ha-ras gene.
Koujitani T; Yasuhara K; Tamura T; Onodera H; Takagi H; Takizawa T; Hirose M; Hayashi Y; Mitsumori K
J Toxicol Sci; 2001 Aug; 26(3):129-39. PubMed ID: 11552296
[TBL] [Abstract][Full Text] [Related]
23. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis.
Tamaoki N
Toxicol Pathol; 2001; 29 Suppl():81-9. PubMed ID: 11695564
[TBL] [Abstract][Full Text] [Related]
24. A 26-week carcinogenicity study of 2-amino-3-methylimidazo[4,5-f]quinoline in rasH2 mice.
Okamura M; Moto M; Muguruma M; Ito T; Jin M; Kashida Y; Mitsumori K
Toxicol Pathol; 2006; 34(2):199-205. PubMed ID: 16537296
[TBL] [Abstract][Full Text] [Related]
25. Lack of susceptibility of transgenic mice carrying the human c-Ha-ras proto-oncogene (rasH2 mice) to phenolphthalein in a 6-month carcinogenicity study.
Koujitani T; Yasuhara K; Usui T; Nomura T; Onodera H; Takagi H; Hirose M; Mitsumori K
Cancer Lett; 2000 May; 152(2):211-6. PubMed ID: 10773414
[TBL] [Abstract][Full Text] [Related]
26. NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
National Toxicology Program, Public Health Services, National Institutes of Health, US Department of Health and Human Services,
Natl Toxicol Program Tech Rep Ser; 2004 May; (512):7-289. PubMed ID: 15213766
[TBL] [Abstract][Full Text] [Related]
27. Carcinogen dose-dependent variation in the transgene mutation spectrum in urethane-induced lung tumors in transgenic mice carrying the human prototype c-Ha-ras gene.
Mori I; Yasuhara K; Hayashi SM; Nonoyama T; Nomura T; Mitsumori K
Cancer Lett; 2000 May; 153(1-2):199-209. PubMed ID: 10779650
[TBL] [Abstract][Full Text] [Related]
28. Tg.rasH2 Mice and not CByB6F1 Mice Should Be Used for 28-Day Dose Range Finding Studies Prior to 26-Week Tg.rasH2 Carcinogenicity Studies.
Paranjpe MG; Belich J; Vidmar TJ; Elbekai RH; McKeon M; Brown C
Int J Toxicol; 2017; 36(4):287-292. PubMed ID: 28553733
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors.
Mitsumori K; Wakana S; Yamamoto S; Kodama Y; Yasuhara K; Nomura T; Hayashi Y; Maronpot RR
Mol Carcinog; 1997 Nov; 20(3):298-307. PubMed ID: 9397190
[TBL] [Abstract][Full Text] [Related]
30. Proposal to Eliminate Urethane-Treated Positive Control Dose Groups in 26-Week Tg.rasH2 Carcinogenicity Studies.
Paranjpe MG; Rudmann D; Sargeant A; Morse M; Yonpiam R; Bonnette K; Albretsen J; Papagiannis C
Int J Toxicol; 2021; 40(3):207-210. PubMed ID: 33813924
[TBL] [Abstract][Full Text] [Related]
31. Glomerulonephritis with fibrillary deposition in a transgenic mouse carrying the human prototype c-Ha-ras gene (rasH2 mouse).
Kobayashi K; Sano F; Mutai M; Sugimoto J
Toxicol Pathol; 2000; 28(2):359-62. PubMed ID: 10805155
[TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
33. NTP Toxicology and Carcinogenesis Studies of Benzene (CAS No. 71-43-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1986 Apr; 289():1-277. PubMed ID: 12748714
[TBL] [Abstract][Full Text] [Related]
34. Studies evaluating the utility of N-methyl-N-nitrosourea as a positive control in carcinogenicity studies in the p53+/- mouse.
Hoivik DJ; Allen JS; Wall HG; Nold JB; Miller RT; Santostefano MJ
Int J Toxicol; 2005; 24(5):349-56. PubMed ID: 16257854
[TBL] [Abstract][Full Text] [Related]
35. A Comparison of Spontaneous Tumors in Tg.rasH2 Mice in 26-week Carcinogenicity Studies Conducted at a Single Test Facility during 2004 to 2012 and 2013 to 2018.
Paranjpe MG; Belich JL; Mann PC; McKeon ME; Elbekai RH; Brown CM; Patrick DJ
Toxicol Pathol; 2019 Jan; 47(1):18-25. PubMed ID: 30407148
[TBL] [Abstract][Full Text] [Related]
36. N-Methyl-N-Nitrosourea (MNU): A positive control chemical for p53+/- mouse carcinogenicity studies.
Morton D; Bailey KL; Stout CL; Weaver RJ; White KA; Lorenzen MJ; Ball DJ
Toxicol Pathol; 2008 Dec; 36(7):926-31. PubMed ID: 18827072
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous tumor incidence in rasH2 mice: review of internal data and published literature.
Nambiar PR; Turnquist SE; Morton D
Toxicol Pathol; 2012 Jun; 40(4):614-23. PubMed ID: 22328410
[TBL] [Abstract][Full Text] [Related]
38. Carcinogenic susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 mice.
Okamura M; Moto M; Kashida Y; Machida N; Mitsumori K
Toxicol Pathol; 2004; 32(4):474-81. PubMed ID: 15223773
[TBL] [Abstract][Full Text] [Related]
39. Reduction in the number of animals and the evaluation period for the positive control group in Tg.rasH2 short-term carcinogenicity studies.
Shah SA; Paranjpe MG; Atkins PI; Zahalka EA
Int J Toxicol; 2012; 31(5):423-9. PubMed ID: 22988008
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 384():1-348. PubMed ID: 12692652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]